abstract |
The use of 5, 6, 7-trihydroxyheρtanoic acid and analogs is disclosed for the treatment of asthma, allergic rhinitis, and skin disorders selected from the group consisting of allergic dermatitis, contact hypersensitivity, urticaria (hives), rosacea and psoriasis. |